News-2 - StoneWise AI

Latest News

More >>

IND Approval | StoneWise's Self-Developed Oral Small-Molecule SWA1211 Secures Clinical Trial Approvals in China and the US

2025-06-13
Events| 2021 ACS Fall Meeting

2021-08-20
StoneWise Raises $100 Million to Boost AI-driven Drug Innovation

2021-04-11
Collaboration | StoneWise Helped Seed Therapeutics Reach a $790 Million Cooperative Development Agreement with Eli Lily

2021-02-05
StoneWise AI-driven Drug Discovery Platform Investigation and Repurpose of Nucleoside-based RNA Polymerase Inhibitors and Their Potential Use in COVID-19 Infection Treatment

2020-02-24

Total of 11 entries, total of 2 pages

Academic progress

More >>

Total of 22 entries, total of 4 pages

Start Your Intelligent Drug Design Journey

MolVado Small Molecule Drug Design Platform – Empowering Your R&D Breakthroughs

产品&服务

StoneWise (HK) Limited

BD Inquiries: bd@stonewise.cn

Customer Service: support@stonewise.cn

Investment Inquiries: ir@stonewise.cn

Media Inquiries: pr@stonewise.cn

Address (Beijing): 10th Floor, Block A, Sinosteel Plaza, No. 8 Haidian Street, Haidian District, Beijing

Address (Shanghai): A3018, No. 1077 Zhang Heng Road, Pudong New Area, Shanghai

StoneWise (HK) Limited

BD Inquiries: bd@stonewise.cn

Customer Service: support@stonewise.cn

Investment Inquiries: ir@stonewise.cn

Media Inquiries: pr@stonewise.cn

Address (Beijing): 10th Floor, Block A, Sinosteel Plaza, No. 8 Haidian Street, Haidian District, Beijing

Address (Shanghai): A3018, No. 1077 Zhang Heng Road, Pudong New Area, Shanghai